Contact
Please use this form to send email to PR contact of this press release:
MeiraGTx Announces AAV-CNGA3 Granted Rare Pediatric Disease Designation by the U.S. FDA for the Treatment of Achromatopsia
TO:
Please use this form to send email to PR contact of this press release:
MeiraGTx Announces AAV-CNGA3 Granted Rare Pediatric Disease Designation by the U.S. FDA for the Treatment of Achromatopsia
TO: